Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BELANTAMAB MAFODOTIN-BLMF: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

48.3%
Female
51.7%
Male

Age Information

The average age of patients reporting adverse events with BELANTAMAB MAFODOTIN-BLMF is 65.9 years.

Geographic Distribution

The majority of adverse event reports for BELANTAMAB MAFODOTIN-BLMF originate from US.

Report Summary & Outcomes

150
Total Reports
150
As Primary/Secondary Suspect
60
Deaths Reported
36
Hospitalizations
5
Life-Threatening
1
Disabilities

Reporting Timeline

First adverse event report: 202005. Most recent report: 20250801. View full timeline →

More About BELANTAMAB MAFODOTIN-BLMF

BELANTAMAB MAFODOTIN-BLMF Full Profile Reports by Year Drug Interactions